Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry”

Detalles Bibliográficos
Autores principales: van Vollenhoven, Ronald F, Tas, Sander W, Nurmohamed, Michael T
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359557/
https://www.ncbi.nlm.nih.gov/pubmed/34389606
http://dx.doi.org/10.1136/annrheumdis-2021-221146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10359557/
https://www.ncbi.nlm.nih.gov/pubmed/34389606
http://dx.doi.org/10.1136/annrheumdis-2021-221146

Ejemplares similares